1. Home
  2. BPMC vs FBIN Comparison

BPMC vs FBIN Comparison

Compare BPMC & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • FBIN
  • Stock Information
  • Founded
  • BPMC 2008
  • FBIN 1988
  • Country
  • BPMC United States
  • FBIN United States
  • Employees
  • BPMC N/A
  • FBIN N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • FBIN Building Products
  • Sector
  • BPMC Health Care
  • FBIN Consumer Discretionary
  • Exchange
  • BPMC Nasdaq
  • FBIN Nasdaq
  • Market Cap
  • BPMC 5.8B
  • FBIN 6.1B
  • IPO Year
  • BPMC 2015
  • FBIN N/A
  • Fundamental
  • Price
  • BPMC $128.20
  • FBIN $50.18
  • Analyst Decision
  • BPMC Buy
  • FBIN Buy
  • Analyst Count
  • BPMC 20
  • FBIN 12
  • Target Price
  • BPMC $127.82
  • FBIN $79.42
  • AVG Volume (30 Days)
  • BPMC 6.4M
  • FBIN 2.5M
  • Earning Date
  • BPMC 07-31-2025
  • FBIN 07-24-2025
  • Dividend Yield
  • BPMC N/A
  • FBIN 1.99%
  • EPS Growth
  • BPMC N/A
  • FBIN 4.88
  • EPS
  • BPMC N/A
  • FBIN 3.42
  • Revenue
  • BPMC $562,121,000.00
  • FBIN $4,532,500,000.00
  • Revenue This Year
  • BPMC $44.46
  • FBIN $0.43
  • Revenue Next Year
  • BPMC $32.78
  • FBIN $3.89
  • P/E Ratio
  • BPMC N/A
  • FBIN $14.67
  • Revenue Growth
  • BPMC 99.19
  • FBIN N/A
  • 52 Week Low
  • BPMC $73.04
  • FBIN $47.21
  • 52 Week High
  • BPMC $128.34
  • FBIN $90.54
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 75.62
  • FBIN 44.64
  • Support Level
  • BPMC $127.86
  • FBIN $49.00
  • Resistance Level
  • BPMC $128.33
  • FBIN $53.87
  • Average True Range (ATR)
  • BPMC 0.41
  • FBIN 1.43
  • MACD
  • BPMC -0.32
  • FBIN -0.04
  • Stochastic Oscillator
  • BPMC 84.62
  • FBIN 32.66

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.3 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $723 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

Share on Social Networks: